Recurrent Nasopharynx Carcinoma
7 clinical trials · Condition
◉ Watch Recurrent Nasopharynx Carcinoma
| Record | Firm | Date |
|---|---|---|
| BGJ398 in Treating Patients With FGFR Positive Recurrent Head and Neck Cancer (NCT02706691) | University of Chicago | 2018-06-01 |
| Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors (NCT03074513) | M.D. Anderson Cancer Center | 2017-03-03 |
| Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by Surgery (NCT02538510) | University of Washington | 2015-10-08 |
| Nivolumab in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Cancer (NCT02339558) | National Cancer Institute (NCI) | 2015-07-21 |
| Autologous Stem Cell Transplantation for Patients With Recurrent Nasopharyngeal Carcinoma (NCT02137096) | University of Florida | 2014-06-01 |
Track Recurrent Nasopharynx Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.